These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 29220288)

  • 1. Contemporary Sarcoma Diagnosis, Genetics, and Genomics.
    Schaefer IM; Cote GM; Hornick JL
    J Clin Oncol; 2018 Jan; 36(2):101-110. PubMed ID: 29220288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.
    Tanas MR; Rubin BP; Tubbs RR; Billings SD; Downs-Kelly E; Goldblum JR
    Arch Pathol Lab Med; 2010 Dec; 134(12):1797-803. PubMed ID: 21128778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of cytogenetics to the management of poorly differentiated sarcomas.
    Bridge JA
    Ultrastruct Pathol; 2008; 32(2):63-71. PubMed ID: 18446669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular biology for sarcoma: useful or necessary?].
    Neuville A; Coindre JM; Chibon F
    Ann Pathol; 2015 Jan; 35(1):107-13. PubMed ID: 25533919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas.
    Lazar A; Abruzzo LV; Pollock RE; Lee S; Czerniak B
    Arch Pathol Lab Med; 2006 Aug; 130(8):1199-207. PubMed ID: 16879024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].
    Schmitz K; Schildhaus HU
    Pathologe; 2015 Mar; 36(2):126-36. PubMed ID: 25822596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetic testing in soft tissue sarcoma.
    Antonescu CR
    Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
    Mariño-Enríquez A; Bovée JV
    Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
    Haller F; Knopf J; Ackermann A; Bieg M; Kleinheinz K; Schlesner M; Moskalev EA; Will R; Satir AA; Abdelmagid IE; Giedl J; Carbon R; Rompel O; Hartmann A; Wiemann S; Metzler M; Agaimy A
    J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluorescence in situ hybridization for the diagnosis of soft-tissue and bone tumors].
    Bertram S; Schildhaus HU
    Pathologe; 2020 Nov; 41(6):589-605. PubMed ID: 32965532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of cytogenetic and fluorescent in situ hybridization analyses in the clinical assessment of soft tissue sarcoma.
    Sozzi G; Minoletti F; Miozzo M; Sard L; Musso K; Azzarelli A; Pierotti MA; Pilotti S
    Hum Pathol; 1997 Feb; 28(2):134-42. PubMed ID: 9023392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities.
    Kao YC; Sung YS; Zhang L; Jungbluth AA; Huang SC; Argani P; Agaram NP; Zin A; Alaggio R; Antonescu CR
    Am J Surg Pathol; 2016 Dec; 40(12):1670-1678. PubMed ID: 27428733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas.
    Yao X; Ghert M; Dickson BC; Popovic S; Purgina BM; Verma S; Werier J; Kandel RA
    Cancer Treat Rev; 2020 Apr; 85():101987. PubMed ID: 32092619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathology of soft tissue sarcomas.
    Sbaraglia M; Dei Tos AP
    Radiol Med; 2019 Apr; 124(4):266-281. PubMed ID: 29948548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors.
    Suurmeijer AJH; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23196. PubMed ID: 37702439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of molecular genetics to paediatric sarcomas.
    Slater O; Shipley J
    J Clin Pathol; 2007 Nov; 60(11):1187-94. PubMed ID: 17468291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience.
    Pei J; Zhao X; Patchefsky AS; Flieder DB; Talarchek JN; Testa JR; Wei S
    Medicine (Baltimore); 2019 Jun; 98(25):e16031. PubMed ID: 31232935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcomas With CIC-rearrangements Are a Distinct Pathologic Entity With Aggressive Outcome: A Clinicopathologic and Molecular Study of 115 Cases.
    Antonescu CR; Owosho AA; Zhang L; Chen S; Deniz K; Huryn JM; Kao YC; Huang SC; Singer S; Tap W; Schaefer IM; Fletcher CD
    Am J Surg Pathol; 2017 Jul; 41(7):941-949. PubMed ID: 28346326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.